Member Info for Malpenn

and expand our investor base particularly in the US.

Nasdaq listing :-)

https://www.sharebuyers.co.uk/shares/4dpharma-shares-going-for-growth-trailblazer-ready-to-realise-true-value/

With Interim results due out around the 25th September, I am hoping we get an update before the results come out.

https://www.businesswire.com/news/home/20200914005237/en/Seattle-Genetics-and-Merck-Announce-Two-Strategic-Oncology-Collaborations

For comedy value I think some one has just purchased 1 share in dddd

Key words are that the units are already in Production and shipping end of Sept.

Can't be long for formal approval and then news flow !!!

Good to see the ABC9 is also being marketed on LinkedIn they are talking about UK and overseas interest.

https://bankofscotlandlive.lbgevent.com/the-big-conversation/login/?utm_source=Twitter&utm_medium=Social&utm_campaign=Big-Conversation

Good to see that Omega are recruiting two new scientist roles.

Primary production scientist
Assist in manufacturing of lateral flow tests.

Product support scientist
Conduct experiments and analysis data for the support of on-market products.

Registrant Organization: Abingdon Health
Registrant State/Province: North Yorkshire
Registrant Country: GB
Registrant Email: Select Contact Domain

When they message you back, can you ask them to add some content here please

https://www.abc19.com/privacy-policy/

Just on their website it says "The test is 99.40% accurate, following production of tens of thousands of tests across multiple production scale batches"

They will have a massive stockpile just waiting for MHRA approval.

CE Mark is the key factor

https://asq.org/quality-resources/ce-marking

https://www.med-technews.com/news/ce-mark-for-covid-19-rapid-antibody-test-welcomed/?_gl=1*ph6rji*_ga*eTl3NTZhSU80dHd5ZFUwOS03ekZjVFRldlc5M0VnU3JfeGlwS29nUUdOUXZxVkttZTBOdGV5dEhkRzNvLUhOOA..

Independent trials will continue throughout the scale-up phase which will lead to CE marking. Following this, additional field trials with the general public will allow MHRA to provide regulatory approval and CE marking for use by the public as a home test.

The AbC-19 lateral flow test uses detector molecules modelled on the “full spike proteins” of the COVID-19 virus making the assay detect antibodies which would bind to the native protein as seen on the virus.

The AbC-19 lateral flow test takes a drop of blood from the patient’s finger and detects whether the blood contains any Immunoglobulin G (IgG) antibodies to COVID-19. IgG antibodies typically begin to appear 7-14 days after an infection.

This followed a request by Professor Sir John Bell, regius professor of medicine at Oxford University, who asked Abingdon Health to work with experts at Oxford to begin the development process.

The next stages, before the kit is manufactured in large volumes, are scale-up of production processes, additional clinical testing and validation, and regulatory approval.

Abingdon Health CEO, Chris Yates said: “The results of our initial trials give us great confidence that our test will meet the regulatory thresholds defined by MHRA for a COVID-19 antibody testing kit. We then look forward to moving to mass production.

“This has been a tremendous company-wide effort at Abingdon Health to achieve this milestone in such a short space of time.

“The AbC-19 lateral flow test has been designed to be used at point of care, initially by healthcare professionals. In time it will also be made available for home use. The AbC-19 test at design freeze shows a 98.6% accuracy.”

Now we just need a speeding ticket tomorrow saying Boris Johnson wasn't supposed to let the cat out of the bag !!!

Or references the community website

https://www.abc19.com/

https://www.bmj.com/content/370/bmj.m3520

Getting ready for the launch...

https://www.abc19.com/